Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2005-09-20
2005-09-20
Kim, Vickie (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C435S325000, C435S004000, C435S029000, C435S395000
Reexamination Certificate
active
06946140
ABSTRACT:
Methods and compositions for enhancing fibroblast migration at a wound site are disclosed. The method includes contacting the wound site with fibrinogen that is prepared by a process which includes precipitating plasma with glycine. The compositions includes a lipid rich component and fibrinogen.
REFERENCES:
patent: 4453939 (1984-06-01), Zimmerman et al.
patent: 4627879 (1986-12-01), Rose et al.
patent: 4950483 (1990-08-01), Ksander et al.
patent: 5024841 (1991-06-01), Chu et al.
patent: 5226877 (1993-07-01), Epstein
patent: 5330974 (1994-07-01), Pines et al.
patent: 5643192 (1997-07-01), Hirsh et al.
patent: 5935850 (1999-08-01), Clark et al.
Gailit et al, Human fibroblasts bind directly to fibrinogen . . . , abstract, Exp. Cell Res. 1997, vol. 232(1), pp. 118-126.
Gailit et al, Studies in vitro on the role of . . . , abstract, J. Invest. Dermatol. (1996), vol. 106(1), pp. 102-108.
Brown et al., Fibroblast migration in Fibrin gel matrices, American Journal of Pathology, vol. 142, 142 No.1, Jan. 1993.
Greiling et al., Fibronectin provides a conduit . . . , Journal of cell science, 1997, vol. 110, pp. 861-870.
DeMoraes et al., Use of autologous fibrin glue in dermatologic surgery . . . , Sao Paulo Medical Journal, 1998, vol. 116(4), pp. 1747-1752.
Gailit et al., Human fibroblast bind directly to fibrinogen . . . , Experimental cell research 1997, VOl. 232, pp. 118-126.
Armani et al., BLOOD, 72(3):919-924 (1988).
Brennan, Blood Reviews, 5:240-244 (1991).
Clark et al., J. Investigative Dermatology, 79(5); 264-269(1982).
Epstein et al. , Ann. Otol. Laryngol., 95:40-45(1986).
Farrugia, et al. TRANFUSION 32(8):755-759(1992).
Finnlayson et al., BIOCHEMISTRY, 2(1):42-46(1963).
Galanakis, Thrombosis Research, 78(4): 303-313(1995).
Greiling et al., J. Cell. Science, 110: 861-870(1997).
Harker et al., New England J. Med., 287(20):999-1005(1972).
Kazal et al., P.S.E.M.B., 113:989-994(1963).
Masri et al., Thromb> Haemostas, 49:116-119(1983).
Mosesson et al., J. Clin. Investigation, 42(6):747-755(1963).
Mosesson et al., BIOCHEMISTRY, 5(9): 2829-2835(1966).
Siedentop et al., LARYGOSCOPE, 95:1074-1076(1985).
Staindi, Ann. Otol., 88:413-418(1979).
Stathakis et al., Thrombosis Research 13:467-475(1978).
Clark Richard A.
Galanakis Dennis K.
Kahn Azmin
Kim Vickie
Rogalskyj & Weyand, LLP.
The Research Foundation of State University of New York
LandOfFree
Methods and compositions for enhancing fibroblast migration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for enhancing fibroblast migration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for enhancing fibroblast migration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3422872